The resources listed below are just some of the convincing statistics, articles and personal testimonies illustrating why WIN is such an important effort. Should you have any questions about the information below, please contact WIN Director Rebecca Ortega at rortega@scai.org.

Professional Importance:

1.   Letter from Carlo DiMario: Why so few women in interventional cardiology?

EAPCI President explains why he is concerned that the quality of interventional cardiology will suffer from the exclusion of the majority of future medical school graduates, who are bound to be women.

2.   MedScape 2011 Physician Compensation Report

Female cardiologists in the U.S. earn markedly lower salaries than their male counterparts (median of $249,000 compared to $340,000).

3.   WIN Professional Development White Paper - COMING 2012

Research-Based Importance:

1.   Heart Disease and Stroke Statistics: 2011 Update

This report from the American Heart Association details the latest findings on prevelance and risk.

2.   WIN White Paper: New Report and Survey Findings Highlighting Why More Women Die From Heart Disease Than Men

Interventional Cardiologists Emphasize Gap in CVD Treatment and Research for Women

3.   Peripheral Arterial Disease Affects More Women Than Men: “A Call to Action: Women and Peripheral Artery Disease”

American Heart Association's Statement on PAD - more physician and public education recommended.

4.   Association of Age and Sex with Myocardio Infarction (MI) Symptom Presentation and In-Hospital Mortality

Female MI Patients Less Likely to Present with Chest Pain - The Journal of the American Medical Association (JAMA)

5.   Associations with Pregnancy Complications with Calculated Cardiovascular Disease Risk

Pregnancy Complications Increase CVD Risk by 30% - AHA Circulation Journal

Government Attention to Women and Heart Disease:

1.   Women's Health Research: Progress, Pitfalls and Promise

Institute of Medicine (IOM) Report

2.   Draft Guidance - Evaluation of Sex Differences in Medical Device Clinical Studies

Food and Drug Administration (FDA) issues guidance to medical device manufacturers outlining agency recommendations for designing and conducting device clinical studies that may enhance the enrollment of women in such studies.

3.   Draft Report - Comparative Effectiveness of Treatment Strategies for Women with Coronary Artery Disease (expired)

Agengy for Healthcare Research and Quality (AHRQ)